For some, the term machine learning may conjure up images of virtual assistants or automated tools.
Zimprich joins from Honeywell, where he led global business communications.
By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.
Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
Somatix is a digital health platform that tracks movements through smartwatches.
In his first press conference as president-elect, Donald Trump insisted pharma was "getting away with murder" due to expensive drug prices.
Some microinfluencers see the latest YouTube guidelines as a "slap in the face."
Advertisers have until July to get their mobile pages up to speed.
Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer
The tech that's most likely to survive post-CES hype is voice but brands should rethink their gendered approach.
New research calls into question the behavioral effects of some digital health tools.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market